0001209191-23-037613.txt : 20230615
0001209191-23-037613.hdr.sgml : 20230615
20230615210029
ACCESSION NUMBER: 0001209191-23-037613
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harris Todd
CENTRAL INDEX KEY: 0001711463
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40800
FILM NUMBER: 231019168
MAIL ADDRESS:
STREET 1: 30699 RUSSELL RANCH ROAD
STREET 2: SUITE 140
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tyra Biosciences, Inc.
CENTRAL INDEX KEY: 0001863127
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831476348
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (619) 728-4760
MAIL ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-13
0
0001863127
Tyra Biosciences, Inc.
TYRA
0001711463
Harris Todd
C/O TYRA BIOSCIENCES, INC.
2656 STATE STREET
CARLSBAD
CA
92008
1
1
0
0
Chief Executive Officer
1
Common Stock
2023-06-13
4
M
0
7927
2.25
A
1709203
D
Common Stock
2023-06-13
4
S
0
7927
16.0048
D
1701276
D
Common Stock
2023-06-15
4
M
0
12773
2.25
A
1714049
D
Common Stock
2023-06-15
4
S
0
12773
16.1275
D
1701276
D
Stock Option (Right to Buy)
2.25
2023-06-13
4
M
0
7927
0.00
D
2031-03-09
Common Stock
7927
389610
D
Stock Option (Right to Buy)
2.25
2023-06-15
4
M
0
12773
0.00
D
2031-03-09
Common Stock
12773
376837
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022.
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.60. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date.
/s/ Ali D. Fawaz, Attorney-in-Fact
2023-06-15